Related Experiment Video
Updated: Feb 16, 2026

The Mouse Stroke Unit Protocol with Standardized Neurological Scoring for Translational Mouse Stroke Studies
Published on: February 7, 2025
CHA2 DS2 -VASc scores for outcome prediction in acute ischaemic stroke
Chun-Hung Su1,2, Teng-Fu Tsao3,4, An-Chih Chen1,2
1Division of Cardiology, Department of Internal Medicine, Chung-Shan Medical University Hospital Taichung, Taichung, Taiwan.
Insights
The CHA2DS2-VASc score, used for atrial fibrillation (AF) patients, can predict stroke severity and long-term outcomes in acute ischemic stroke patients. This score offers better clinical value than CHADS2 for predicting outcomes.
Area of Science:
- Neurology
- Cardiology
- Stroke Medicine
Background:
- CHADS2 and CHA2DS2-VASc scores are established risk stratification tools for stroke in atrial fibrillation (AF) patients.
- Their utility in predicting acute ischemic stroke severity and long-term outcomes remains an area of investigation.
Purpose of the Study:
- To evaluate the predictive value of prestroke CHADS2 and CHA2DS2-VASc scores for infarction severity and long-term outcomes in acute ischemic stroke patients.
- To compare the predictive performance of these scores in patients with and without AF.
Main Methods:
- Prospective study of 1494 acute ischemic stroke patients without hemorrhagic transformation.
- Infarction volume and arterial stenosis assessed via MR imaging.
- NIH Stroke Scale (NIHSS) scores recorded at admission and discharge.
- Clinical outcomes (restroke, mortality) followed for a mean of 37.5 months.
Main Results:
- Patients with AF (13.1%) had higher CHADS2 and CHA2DS2-VASc scores.
- Higher scores correlated with increased infarction volume, arterial stenosis, NIHSS scores, and poorer outcomes.
- After adjustment, only CHA2DS2-VASc scores predicted restroke and composite endpoints.
Conclusions:
- Prestroke CHA2DS2-VASc scores demonstrate significant clinical value in predicting infarction severity and long-term outcomes.
- The CHA2DS2-VASc score appears superior to the CHADS2 score for this predictive purpose in acute ischemic stroke patients, irrespective of AF status.
Background:
The CHADS2 and CHA2 DS2 -VASc scores are clinical risk stratification instruments that are used clinically to assess the risk of stroke in patients with atrial fibrillation (AF). The aim of this study was to evaluate whether the prestroke CHADS2 and CHA2 DS2 -VASc scores could be useful for predicting infarction severity and long-term outcomes in patients with acute ischaemic stroke.
Materials And Methods:
This prospective study included all 1494 patients who had acute ischaemic stroke without haemorrhagic transformation which was evidenced with magnetic resonance (MR) imaging during hospitalization. Total infarction volume and arterial stenosis score were calculated based on MR imaging. National Institutes of Health Stroke Scale scores (NIHSSs) were obtained at admission and discharge by board-certified neurologists. The clinical outcomes were defined as composite endpoints of restroke and mortality and were recorded with the mean follow-up period of 37.5 months.
Results:
There were 195 (13.1%) patients with AF. The patients with AF had significantly higher median CHADS2 and CHA2 DS2 -VASc scores than the patients without AF (P < .001). Patients with higher CHADS2 and CHA2 DS2 -VASc scores had significantly higher total infarction volume, arterial stenosis score and NIHSS scores at discharge and poorer clinical outcomes. After adjusting for age, gender and AF, only CHA2 DS2 -VASc scores could predict both restroke and composite endpoints.
Conclusions:
Prestroke CHA2 DS2 -VASc scores appear to have better clinical value for predicting the severity of infarction and long-term clinical outcomes in acute ischaemic stroke patients with and without AF.
Related Concept Videos
Predicting Reaction Outcomes
Introduction to z Scores
z scores...
Introduction to z Scores
z scores...
z Scores and Area Under the Curve
Predicting Molecular Geometry
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

